These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 31941454

  • 1. The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey.
    Lingani M, Akita T, Ouoba S, Nagashima S, Boua PR, Takahashi K, Kam B, Sugiyama A, Nikiema T, Yamamoto C, Somé A, Derra K, Ko K, Sorgho H, Tarnagda Z, Tinto H, Tanaka J.
    BMC Infect Dis; 2020 Jan 15; 20(1):46. PubMed ID: 31941454
    [Abstract] [Full Text] [Related]

  • 2. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y, Liu SL, Zhai XJ, Zhu FC, Pan H, Yu JX, Chen YZ, Xie YR, Zhang XY, Zhang HM, Li LJ, Wang H, Ruan B.
    J Med Virol; 2009 Sep 15; 81(9):1517-24. PubMed ID: 19626618
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Ork V, Woodring J, Shafiqul Hossain M, Wasley A, Nagashima S, Yamamoto C, Chuon C, Sugiyama A, Ohisa M, Akita T, Ko K, Mao B, Tanaka J.
    Vaccine; 2019 Aug 14; 37(35):5059-5066. PubMed ID: 31285088
    [Abstract] [Full Text] [Related]

  • 4. Existence of hepatitis B virus surface protein mutations and other variants: demand for hepatitis B infection control in Cambodia.
    Ko K, Takahashi K, Nagashima S, Yamamoto C, Ork V, Sugiyama A, Akita T, Ohisa M, Chuon C, Hossain MS, Mao B, Tanaka J.
    BMC Infect Dis; 2020 Apr 25; 20(1):305. PubMed ID: 32334529
    [Abstract] [Full Text] [Related]

  • 5. World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
    Diarra B, Yonli AT, Ouattara AK, Zohoncon TM, Traore L, Nadembega C, Obiri-Yeboah D, Yara J, Pietra V, Ouedraogo P, Bougouma A, Sanogo R, Simpore J.
    Virol J; 2018 Aug 06; 15(1):121. PubMed ID: 30081915
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region.
    Sanou AM, Ilboudo AK, Meda CZ, Togozia A, Coulibaly A, Cisse A, Sagna T, Kania D, Tarnagda Z.
    J Infect Dev Ctries; 2018 Nov 30; 12(11):1002-1008. PubMed ID: 32012131
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections.
    Candotti D, Diarra B, Bisseye C, Tao I, Pham Quang K, Sanou M, Laperche S, Sanogo R, Allain JP, Simpore J.
    J Med Virol; 2016 Dec 30; 88(12):2145-2156. PubMed ID: 27253483
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of Hepatitis B virus and Hepatitis D virus Coinfection in Western Burkina Faso and molecular characterization of the detected virus strains.
    Sanou AM, Benkirane K, Tinto B, Cissé A, Sagna T, Ilboudo AK, Dording C, Tarnagda Z, Muller CP, Hübschen JM.
    Int J Infect Dis; 2018 May 30; 70():15-19. PubMed ID: 29432880
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination.
    Yao QQ, Dong XL, Wang XC, Ge SX, Hu AQ, Liu HY, Wang YA, Yuan Q, Zheng YJ.
    Clin Vaccine Immunol; 2013 Feb 30; 20(2):269-75. PubMed ID: 23254298
    [Abstract] [Full Text] [Related]

  • 10. [Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso].
    Sangaré L, Sombié R, Combasséré AW, Kouanda A, Kania D, Zerbo O, Lankoandé J.
    Bull Soc Pathol Exot; 2009 Oct 30; 102(4):226-9. PubMed ID: 19950539
    [Abstract] [Full Text] [Related]

  • 11. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
    Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilisteanu D, Radasan A, Micu G, Pertache I.
    J Gastrointestin Liver Dis; 2010 Mar 30; 19(1):43-8. PubMed ID: 20361074
    [Abstract] [Full Text] [Related]

  • 12. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B, Mihret A, Aseffa A, Tarekegne A, Hussen S, Wachamo D, Shimelis T, Howe R.
    BMC Infect Dis; 2020 Jul 22; 20(1):528. PubMed ID: 32698884
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study.
    Pinto FP, Ferreira OC, Olmedo DB, Precioso PM, Barquette FR, Castilho MC, Silva SG, Pôrto LC.
    Ann Hepatol; 2015 Jul 22; 14(6):815-25. PubMed ID: 26436353
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.
    Ashraf H, Alam NH, Rothermundt C, Brooks A, Bardhan P, Hossain L, Salam MA, Hassan MS, Beglinger C, Gyr N.
    BMC Infect Dis; 2010 Jul 15; 10():208. PubMed ID: 20630111
    [Abstract] [Full Text] [Related]

  • 15. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [Abstract] [Full Text] [Related]

  • 16. Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan.
    Chang KC, Chang MH, Chen HL, Cheng FW, Wu JF, Su WJ, Hsu HY, Ni YH.
    Liver Int; 2024 Aug 16; 44(8):2054-2062. PubMed ID: 38700381
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP, Nouanthong P, Nanthavong N, Souvannaso C, Vilivong K, Jutavijittum P, Samountry B, Lütteke N, Hübschen JM, Goossens S, Quet F, Buisson Y, Muller CP.
    BMC Infect Dis; 2014 Aug 23; 14():457. PubMed ID: 25149478
    [Abstract] [Full Text] [Related]

  • 18. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T, Ishii K, Mizokami M, Sugiyama M, Wakita T.
    Vaccine; 2015 Nov 09; 33(45):6037-42. PubMed ID: 26341564
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps.
    Tshering N, Dhakal GP, Wangchuk U, Wangdi S, Khandu L, Pelden S, Nogareda F, Patel MK, Hutin YJF, Wannemuehler K, Rewari BB, Wangchuk S.
    BMC Infect Dis; 2020 Jul 08; 20(1):485. PubMed ID: 32641006
    [Abstract] [Full Text] [Related]

  • 20. Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
    Breakwell L, Marke D, Kaiser R, Tejada-Strop A, Pauly MD, Jabbi S, Yambasu S, Kabore HJ, Stewart B, Sesay T, Samba TT, Hayden T, Kamili S, Jambai A, Drobeniuc J, Singh T, Tohme RA, Wasley A.
    Vaccine; 2022 Apr 26; 40(19):2741-2748. PubMed ID: 35361502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.